hli logo
Image from Coce

Essential endocrinology and diabetes / Richard I.G. Holt, Neil A. Hanley.

By: Contributor(s): Material type: TextTextSeries: Essentials (Wiley-Blackwell (Firm))Publisher: Hoboken, NJ : John Wiley & Sons, Inc., 2021Edition: Seventh editionDescription: x, 318 p. ; ill. 28 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9781118763964
Subject(s): DDC classification:
  • 616.4 23
LOC classification:
  • RC649
NLM classification:
  • WK 100
Contents:
Overview of endocrinology -- Basic cell biology and hormone synthesis -- Molecular basis of hormone action -- Investigations in endocrinology and diabetes -- Hypothalamus and pituitary gland -- Adrenal gland -- Reproductive endocrinology -- Thyroid gland -- Calcium and metabolic bone disorders -- Pancreatic and gastrointestinal endocrinology and endocrine neoplasia -- Overview of diabetes -- Type 1 diabetes -- Type 2 diabetes -- Complications of diabetes -- Obesity.
Summary: "The textbook aims to be valued by different groups of reader. Its core purpose is still to provide a foundation from understanding the science to clinical training in undergraduate medicine. In addition, the content here should also be invaluable for postgraduate clinicians training in the specialty of endocrinology and diabetes. Written 'exit' examinations have become increasingly common during the later stages of clinical specialty training and we hope our textbook provides complementary study material alongside larger reference textbooks and published clinical guidelines. From feedback, we realise that our book has been valued by biomedical undergraduate and masters students and by those pursuing clinical biochemistry. We hope the new content increases this reach across different audiences. Learning objectives, recap points, cross-referencing guides, boxes, and concluding key points help orientate the reader and emphasize the major topics. Based on the success of previous editions, the book is still structured in much the same way. The first part is designed to create a knowledgeable reader, well prepared for the clinical sections or for more specific scientific study. To assist the many students coming from non-scientific backgrounds we limit assumptions on prior knowledge. Chapter 1 still covers the core principle of feedback regulation which underlies nearly all endocrine physiology and is vital for the correct interpretation of many clinical tests. Chapter 3 has advanced to encompass the latest research made possible from next generation sequencing technology. The latter has already started to impact significantly on clinical investigation and diagnostics in endocrinology and diabetes. This is covered in Chapter 4, which also includes positron emission tomography (PET) imaging. It is important that aspiring clinicians, as well as scientists, appreciate these new approaches, their application and their challenges. The second part of the book still follows its organ or system-based approach. We have retained the more specific scientific knowledge at the start of these chapters to underpin understanding, diagnosing and managing the relevant clinical disorders. The third part on diabetes and obesity has seen the greatest change from the previous edition. Over the last 8 years, there have been significant advances in the treatment of both type 2 diabetes, such as the new incretin-based therapies and SGLT2 inhibitors, and type 1 diabetes with the development of better insulins and the use of technology to support self-management. Clinical algorithms have also changed and these have been updated"-- Provided by publisher.
Item type: 4 Week Loan List(s) this item appears in: ConnollyHospital New Medical books 2021 | St. Columcille's Hospital Library New Books 2022
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Shelving location Call number Status Notes Date due Barcode Item holds
4 Week Loan Connolly Hospital Dublin Connolly Hospital Dublin Book 616.4 HOL (Browse shelf(Opens below)) Available 128041
4 Week Loan Mayo University Hospital Mayo University Hospital 616.462/HOL (Browse shelf(Opens below)) Available (Not Restricted) MG08822
4 Week Loan Midland Regional Hospital Library Portlaoise Midland Regional Hospital Library Portlaoise Loan collection MRH Portlaoise 616.462 HOL (Browse shelf(Opens below)) Available PT40120
4 Week Loan Naas General Hospital Library Naas General Hospital Library Book 616.4 (Browse shelf(Opens below)) Available 222252
4 Week Loan Our Lady’s Hospital Library, Navan Our Lady’s Hospital Library, Navan Book 616.462 (Browse shelf(Opens below)) Available NA20244
4 Week Loan Portiuncula University Hospital Portiuncula University Hospital Library Portiuncula Ballinasloe 616.462/HOL (Browse shelf(Opens below)) Available PH03593
4 Week Loan St. Columcille’s Hospital Dublin St. Columcille’s Hospital Dublin Book 616.4 HOL (Browse shelf(Opens below)) Available ENDO-DIAB 140388
4 Week Loan University Hospital Galway University Hospital Galway 616.462/HOL (Browse shelf(Opens below)) Available RE07509
Total holds: 0

Includes bibliographical references and index.

Overview of endocrinology -- Basic cell biology and hormone synthesis -- Molecular basis of hormone action -- Investigations in endocrinology and diabetes -- Hypothalamus and pituitary gland -- Adrenal gland -- Reproductive endocrinology -- Thyroid gland -- Calcium and metabolic bone disorders -- Pancreatic and gastrointestinal endocrinology and endocrine neoplasia -- Overview of diabetes -- Type 1 diabetes -- Type 2 diabetes -- Complications of diabetes -- Obesity.

"The textbook aims to be valued by different groups of reader. Its core purpose is still to provide a foundation from understanding the science to clinical training in undergraduate medicine. In addition, the content here should also be invaluable for postgraduate clinicians training in the specialty of endocrinology and diabetes. Written 'exit' examinations have become increasingly common during the later stages of clinical specialty training and we hope our textbook provides complementary study material alongside larger reference textbooks and published clinical guidelines. From feedback, we realise that our book has been valued by biomedical undergraduate and masters students and by those pursuing clinical biochemistry. We hope the new content increases this reach across different audiences. Learning objectives, recap points, cross-referencing guides, boxes, and concluding key points help orientate the reader and emphasize the major topics. Based on the success of previous editions, the book is still structured in much the same way. The first part is designed to create a knowledgeable reader, well prepared for the clinical sections or for more specific scientific study. To assist the many students coming from non-scientific backgrounds we limit assumptions on prior knowledge. Chapter 1 still covers the core principle of feedback regulation which underlies nearly all endocrine physiology and is vital for the correct interpretation of many clinical tests. Chapter 3 has advanced to encompass the latest research made possible from next generation sequencing technology. The latter has already started to impact significantly on clinical investigation and diagnostics in endocrinology and diabetes. This is covered in Chapter 4, which also includes positron emission tomography (PET) imaging. It is important that aspiring clinicians, as well as scientists, appreciate these new approaches, their application and their challenges. The second part of the book still follows its organ or system-based approach. We have retained the more specific scientific knowledge at the start of these chapters to underpin understanding, diagnosing and managing the relevant clinical disorders. The third part on diabetes and obesity has seen the greatest change from the previous edition. Over the last 8 years, there have been significant advances in the treatment of both type 2 diabetes, such as the new incretin-based therapies and SGLT2 inhibitors, and type 1 diabetes with the development of better insulins and the use of technology to support self-management. Clinical algorithms have also changed and these have been updated"-- Provided by publisher.

There are no comments on this title.

to post a comment.